News
-
-
-
-
-
-
-
-
PRESS RELEASE
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
Bausch Health Companies Inc. presents positive data from Amiselimod clinical trials for ulcerative colitis treatment at global healthcare conferences. Rifaximin monotherapy data also showed promise for hepatic encephalopathy recurrence prevention -
-